Literature DB >> 23669282

Reliability of the estimation of total hepatic blood flow by Doppler ultrasound in patients with cirrhotic portal hypertension.

Annalisa Berzigotti1, Enric Reverter, Angeles García-Criado, Juan G Abraldes, Federica Cerini, Juan Carlos García-Pagán, Jaime Bosch.   

Abstract

BACKGROUND & AIMS: Hepatic blood flow (HBF) is best estimated by the Fick's method during indocyanine green constant infusion (ICG-HBF) on hepatic vein catheterization. We investigated the consistency and agreement of HBF measured by Doppler ultrasound (US-HBF) as compared with ICG-HBF in portal hypertensive patients with cirrhosis.
METHODS: In 50 patients observed for HVPG measurement (56% compensated; Child score 7 ± 2; HVPG 16.6 ± 6.0 mmHg; varices in 75%) US-HBF (Sequoia-512-Acuson; 4.5-7 MHz convex probe; US-HBF = hepatic artery blood flow+portal vein blood flow) and ICG-HBF (Fick's method after an equilibration period of at least 45 min of ICG bolus of 5 mg + constant rate infusion of 0.2 mg/min). Intraclass correlation coefficient (ICC) for consistency and absolute agreement between US-HBF and ICG-HBF were calculated.
RESULTS: Mean ICG-HBF and US-HBF were similar, being respectively 1004 ± 543 ml/min and 994 ± 494 ml/min (p = 0.661 vs. ICG-HBF). However, results in individual patients disclosed marked differences between the two methods (386 ± 415 ml/min) and showed only moderate consistency (ICC 0.456; p < 0.0001), absolute agreement (ICC 0.461; p < 0.0001) and linear correlation (R = 0.464; p < 0.0001). The discrepancy between the two methods was maximal in patients with poor liver function, high HBF by any technique and more arterialized liver circulation. Hepatic artery blood flow ≥40% of US-HBF indicated, with 90% specificity, a discrepancy ≥20% between US-HBF and ICG-HBF.
CONCLUSIONS: HBF estimations by Doppler-ultrasound and ICG are significantly correlated, but their discrepancy in individual cases is high. Estimation of HBF by Doppler-US should be considered unreliable in patients with poor hepatic function and large liver arterialization.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  HVPG; Hepatic veins; Non-invasive methods; Portal hypertension

Mesh:

Substances:

Year:  2013        PMID: 23669282     DOI: 10.1016/j.jhep.2013.04.037

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  8 in total

1.  Geometric modeling of hepatic arteries in 3D ultrasound with unsupervised MRA fusion during liver interventions.

Authors:  Maxime Gérard; François Michaud; Alexandre Bigot; An Tang; Gilles Soulez; Samuel Kadoury
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-03-07       Impact factor: 2.924

Review 2.  Noninvasive assessment of liver function.

Authors:  Steve Helmke; Jordi Colmenero; Gregory T Everson
Journal:  Curr Opin Gastroenterol       Date:  2015-05       Impact factor: 3.287

3.  Correlation between hepatic blood flow and liver function in alcoholic liver cirrhosis.

Authors:  Hideaki Takahashi; Ryuta Shigefuku; Yoshihito Yoshida; Hiroki Ikeda; Kotaro Matsunaga; Nobuyuki Matsumoto; Chiaki Okuse; Shigeru Sase; Fumio Itoh; Michihiro Suzuki
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 4.  The accuracy of ultrasonography for the evaluation of portal hypertension in patients with cirrhosis: a systematic review.

Authors:  Gaeun Kim; Youn Zoo Cho; Soon Koo Baik; Moon Young Kim; Won Ki Hong; Sang Ok Kwon
Journal:  Korean J Radiol       Date:  2015-02-27       Impact factor: 3.500

5.  Transhepatic-intrahepatic branches of the portal vein catheterization for ex vivo liver resection and autotransplantation: Two case reports of novel approach to perfuse the liver.

Authors:  Junjie Kong; Shu Shen; Xianwei Yang; Wentao Wang
Journal:  Medicine (Baltimore)       Date:  2019-03       Impact factor: 1.817

6.  Preoperative color Doppler ultrasonography predicts early recurrence in AFP-positive hepatocellular carcinoma.

Authors:  Miao Chen; Duo Wang; Yuan Zhao; Dan-Mei Lu; Hong-Xue Li; Jun-Jie Liu; Hang Li
Journal:  Oncol Lett       Date:  2019-09-09       Impact factor: 2.967

7.  Non-invasive predictive model for hepatic venous pressure gradient based on a 3-dimensional computed tomography volume rendering technology.

Authors:  Yujen Tseng; Lili Ma; Tiancheng Luo; Xiaoqing Zeng; Na Li; Yichao Wei; Ji Zhou; Feng Li; Shiyao Chen
Journal:  Exp Ther Med       Date:  2018-01-30       Impact factor: 2.447

8.  Establishment and assessment of the hepatic venous pressure gradient using biofluid mechanics (HVPGBFM): protocol for a prospective, randomised, non-controlled, multicentre study.

Authors:  Jia-Yun Lin; Chi-Hao Zhang; Lei Zheng; Hui-Song Chen; Hong-Jie Li; Yi-Ming Zhu; Xiao Fan; Feng Li; Yan Xia; Ming-Zhe Huang; Sun-Hu Yang; Xiao-Liang Qi; Hai-Zhong Huo; Xiao-Lou Lou; Meng Luo
Journal:  BMJ Open       Date:  2019-12-03       Impact factor: 2.692

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.